A proposed testing sequence is to first test for HRR aberrations in the tumour (somatic) and only expand to germline testing in those with somatic HRR aberrations. Commercial workflows typically run somatic then germline tests in sequence. In contrast, hospital laboratories conducting their own tests may conduct them in parallel.